docetaxel has been researched along with at 406 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, Q; Guo, M; Kang, S; Leopold, L; Liu, L; Lu, J; McEachern, D; Miller, R; Nikolovska-Coleska, Z; Peng, Y; Qiu, S; Sun, D; Sun, H; Wang, S; Yang, CY; Yang, D; Yi, H; Zhang, T | 1 |
1 other study(ies) available for docetaxel and at 406
Article | Year |
---|---|
A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Area Under Curve; Azocines; Benzhydryl Compounds; Biological Availability; Cell Line, Tumor; Humans; Inhibitor of Apoptosis Proteins; Models, Molecular; Neoplasms | 2011 |